Propantheline    (DrugBank: Propantheline)

1 disease
IDDisease name (Link within this page)Number of trials
26HTLV-1-associated myelopathy1

26. HTLV-1-associated myelopathy    [ 26 clinical trials,   46 drugs,   (DrugBank: 27 drugs),   37 drug target genes,   123 drug target pathways]
Searched query = "HTLV-1-associated myelopathy", "Tropical spastic paraparesis", "HTLV-1", "HTLV-I-associated myelopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 26 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01640002
(ClinicalTrials.gov)
May 201211/7/2012A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive BladderA Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive BladderOveractive Bladder Associated With HTLV-1Drug: Propantheline Bromide;Drug: PlaceboHospital Universitário Professor Edgard SantosNULLRecruiting18 YearsN/ABoth42Phase 1Brazil